Reducing without side effects? A novel strategy for designing the PPAR agonists

ASIA unversity > 資訊學院 > 生物資訊與醫學工程學系 > 會議論文 > Item 310904400/8765

Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/8765

Title:	Reducing without side effects? A novel strategy for designing the PPAR agonists
Authors:	Chang, Yea-Huey;Bau, Da-Tian;Tsai, Ming-Hsui;Hsu, Yuan-Man;Ho, Tin-Yun;Chen, Chien-Yu;Huang, Hung-Jin;Tsai, Fuu-Jen;Tsai, Chang-Hai;Chen, Calvin Yu-Chian
Contributors:	Department of Bioinformatics
Keywords:	Biomedical engineering;Docking;Drug interactions;Sulfur compounds;3D-QSAR;Novel strategies;Pharmacophores;Side effect;Target receptor;Three-dimensional quantitative structure-activity relationship
Date:	2009
Issue Date:	2010-04-08 20:05:51 (UTC+8)
Publisher:	Asia University
Abstract:	In this investigation, the CoMFA and CoMSIA in the three-dimensional quantitative structure-activity relationship (3DQSAR) studies were implemented to search for the pharmacophore features in each target receptor. QSAR pharmacophores hypothesis models were made from a series of ligands by their activity values. Besides, we made use of the docking strategy between the structures of each PPARs subtype. Eventually, selectivity factor is employed for us to search new drugs. By means of taking advantage of the results of 3D-QSAR studies and docking strategy, we search out the specific drugs fitting the two PPAR subtypes but repelling the other PPAR subtype effectively and selectively. ©2009 IEEE.
Relation:	Proceedings of the 2009 2nd International Conference on Biomedical Engineering and Informatics, BMEI 2009
Appears in Collections:	[生物資訊與醫學工程學系 ] 會議論文

Files in This Item:

File	Description	Size	Format
		0Kb	Unknown	528	View/Open
310904400-8765.doc		42Kb	Microsoft Word	462	View/Open